Amryt Pharma Share Discussion Threads

[papillon] 01/12/2021 09:06

I still have the CVR's bazworth.

[moorsie2] 01/12/2021 09:01

He now has a million or so shares at 1.70 average.

He is expecting a very good pay day in time.

Investors need patience as well as bravery...

[bazworth] 30/11/2021 22:24

Good day on the NASDAQ.

[bazworth] 30/11/2021 12:28

It’s irrelevant, the timing that is, in the great scheme of things! Patience will hopefully pay and it’s incredibly difficult and often expensive to trade in & out!!

I thought you had moved on to other more fertile grounds Paps?

[papillon] 30/11/2021 12:03

He bought 300k @ £2 for £600k earlier this year. Not good timing!

[paleje] 30/11/2021 07:41

On top of his very substantial purchase in March at a much higher price. Someone's got confidence.

[ali47fish] 30/11/2021 07:30

chair buys 50,000 ADSs

[brummy_git] 26/11/2021 15:15

AMYT discussed here (33:25)

www.youtube.com/watch?v=4PCSEnaOMA8

[papillon] 26/11/2021 10:49

0 0 0


This was predictable last night. FTSE well down as are most things, including cryptocurrencies. Only gold is bucking the trend and is up.

Definitely a Black Friday!

[waterloo01] 25/11/2021 13:17

Filterwest, Barclays don't do much generally. Most brokers however will trade US stocks onine.

[whatno] 25/11/2021 13:02

We should remember that Oleogel-S10 was approved in 2016 by the EMA for the treatment of partial Thickness Wounds. Given that EB wounds are similar in nature, I would expect the EMA to approve. Clearly, based on the press release, there are some outstanding issues but I can't see any of them being a deal-breaker.

[ali47fish] 25/11/2021 09:05

din when you say offer amyt pounds or dollars?

[richpassi] 25/11/2021 08:18

Thanks for that .... more form filling :(

[dingodollars] 25/11/2021 07:51

Interactive investor offer both Amryt and also the ADRs on their platform, so can't see any issue with it being transferred. Just a question of whether they do it automatically or we have to push a button. First make sure you have filled in some form so you can trade US securities, takes about 2 minutes.

[bazworth] 23/11/2021 22:35

I’m awaiting a reply from iii who hold ours in an ISA. I intend to take the ADR’s

[filterwest] 23/11/2021 22:15

Hi Guys

I hold 5000 shares in Aim and intend to keep it. Do I need to do anything in ADSs on Nasdaq. My account is with Barclays. Very much appreciated if anyone can tell me what I need to do.

[richpassi] 23/11/2021 17:14

Obviously disappointed, firstly by yesterday's news as I felt a lot would sell off due to overseas trading issues then with today's news that just put the boot in further, because Aim trading will be ceased before February. As like a lot of people I hold in an online account (Halifax) and not been in this position before :( Gambler that I am and being in for so long, instinct to me would be to see it through to the end (I know.....idiot) if the shares are able to be converted in my ISA and tradeable within it too. So I had a webchat with Halifax and at first the person said NO they do not trade ADS but when I showed them I can purchase them today in ADS's within my ISA they were surprised and said it seems they have been trading them since March, have to wait to see Corporate Action notice, but feel its not going to be difficult to continue the bet !!! Any one else had any feed back regarding this matter ? Ps I did sell £5000 that I bought in August at evens before I spoke online.

[brummy_git] 23/11/2021 17:08

A very busy couple of days for Amryt Pharma

Find out here my latest views & 'back of the envelope' valuation.

www.linkedin.com/posts/paul-hill-a5994116_amyt-amyt-amyt-activity-6868953188607819776-bGHb

[waterloo01] 23/11/2021 16:55

Sensible view, although I think it's probably a bit more of a setback with regulators. Just a feel.

[cwa1] 23/11/2021 16:53

With link to Amryt comment

[chica1] 23/11/2021 16:37

It looks like the EMA have issues with the filing as well.
I told you guys years ago that Episalvan,Olegel or Filsuvez,what ever you want to call it,does not work.



'The European Medicines Agency (“EMA”) review process for Oleogel-S10 in EB is ongoing and Amryt is in the process of responding to the remaining Major Objections in the List of Outstanding Issues sent by the EMA. The Committee for Medicinal Products for Human Use (“CHMP”) opinion is now expected in January 2022.'